Skip to main content
. 2017 Apr 20;8(30):49515–49533. doi: 10.18632/oncotarget.17259

Table 6. Mixed evidence of recurrence for different treatments.

Ble+Cis+Ifo Ble+Cis+MitoC+Vbl Ble+Cis+Vbl Ble+Cis+Vcr Cis Cis+Doc Cis+Epi Cis+Flu Cis+Ifo Cis+Ifo+Pac Cis+Methotrexate Cis+Mitolactol Cis+Topotecan Cis+Vcr Epi Flu Cis+Flu+Hyd Flu+MitoC Hyd Placebo
Ble+Cis+Ifo Ble+Cis+Ifo 1.73 (0.33, 8.40) 1.68 (0.48, 5.90) 1.77 (0.53, 5.58) 0.85 (0.33, 2.06) 0.51 (0.11, 2.12) 1.72 (0.44, 6.58) 0.65 (0.25, 1.59) 0.24 (0.07, 0.74) 0.22 (0.04, 1.09) 1.18 (0.23, 5.85) 0.91 (0.17, 5.27) 0.61 (0.13, 2.89) 1.50 (0.37, 5.48) 0.77 (0.18, 2.93) 0.73 (0.25, 2.00) 0.62 (0.16, 2.13) 0.56 (0.15, 1.92) 1.02 (0.33, 2.68) 1.43 (0.61, 3.20)
Ble+Cis+MitoC+Vbl 0.58 (0.12, 2.99) Ble+Cis+MitoC+Vbl 0.98 (0.19, 5.19) 1.04 (0.21, 5.24) 0.49 (0.11, 2.13) 0.30 (0.05, 1.81) 1.01 (0.17, 5.95) 0.38 (0.09, 1.61) 0.14 (0.02, 0.86) 0.13 (0.02, 1.08) 0.69 (0.10, 4.76) 0.53 (0.07, 5.08) 0.36 (0.05, 2.47) 0.87 (0.16, 4.95) 0.44 (0.08, 2.62) 0.42 (0.09, 1.93) 0.36 (0.07, 1.90) 0.33 (0.06, 1.74) 0.59 (0.13, 2.53) 0.84 (0.21, 3.32)
Ble+Cis+Vbl 0.60 (0.17, 2.10) 1.02 (0.19, 5.34) Ble+Cis+Vbl 1.06 (0.29, 3.76) 0.50 (0.17, 1.46) 0.30 (0.06, 1.42) 1.02 (0.25, 4.33) 0.38 (0.13, 1.10) 0.14 (0.03, 0.65) 0.13 (0.02, 0.87) 0.70 (0.13, 3.75) 0.54 (0.09, 3.82) 0.37 (0.07, 1.85) 0.89 (0.20, 3.71) 0.46 (0.10, 1.99) 0.43 (0.13, 1.36) 0.37 (0.09, 1.44) 0.33 (0.08, 1.28) 0.60 (0.19, 1.78) 0.85 (0.33, 2.19)
Ble+Cis+Vcr 0.56 (0.18, 1.88) 0.97 (0.19, 4.83) 0.95 (0.27, 3.39) Ble+Cis+Vcr 0.48 (0.18, 1.25) 0.29 (0.06, 1.27) 0.97 (0.25, 3.76) 0.37 (0.14, 0.94) 0.14 (0.03, 0.57) 0.12 (0.02, 0.78) 0.67 (0.13, 3.31) 0.51 (0.09, 3.56) 0.34 (0.07, 1.69) 0.84 (0.21, 3.27) 0.43 (0.10, 1.70) 0.41 (0.14, 1.17) 0.35 (0.09, 1.27) 0.31 (0.09, 1.12) 0.57 (0.19, 1.53) 0.81 (0.35, 1.87)
Cis 1.18 (0.48, 3.05) 2.03 (0.47, 8.74) 1.99 (0.68, 5.73) 2.10 (0.80, 5.45) Cis 0.60 (0.19, 1.86) 2.05 (0.64, 6.67) 0.76 (0.44, 1.31) 0.29 (0.09, 0.89) 0.26 (0.05, 1.31) 1.40 (0.32, 6.03) 1.07 (0.23, 6.03) 0.73 (0.21, 2.59) 1.77 (0.55, 5.67) 0.91 (0.27, 3.02) 0.85 (0.42, 1.71) 0.74 (0.27, 1.84) 0.66 (0.23, 1.89) 1.21 (0.59, 2.18) 1.69 (1.06, 2.68)
Cis+Doc 1.97 (0.47, 8.71) 3.38 (0.55, 21.43) 3.35 (0.71, 16.05) 3.51 (0.79, 15.93) 1.68 (0.54, 5.27) Cis+Doc 3.39 (0.66, 18.11) 1.28 (0.36, 4.55) 0.48 (0.10, 2.47) 0.44 (0.06, 3.23) 2.34 (0.37, 14.68) 1.81 (0.26, 14.25) 1.22 (0.22, 6.64) 2.97 (0.57, 15.12) 1.52 (0.29, 8.02) 1.44 (0.37, 5.51) 1.23 (0.26, 5.29) 1.12 (0.23, 5.28) 2.01 (0.50, 7.15) 2.84 (0.82, 9.70)
Cis+Epi 0.58 (0.15, 2.27) 0.99 (0.17, 5.72) 0.98 (0.23, 4.08) 1.03 (0.27, 4.03) 0.49 (0.15, 1.55) 0.29 (0.06, 1.51) Cis+Epi 0.38 (0.11, 1.19) 0.14 (0.03, 0.68) 0.13 (0.02, 0.91) 0.68 (0.12, 3.88) 0.53 (0.08, 3.96) 0.36 (0.06, 1.93) 0.87 (0.19, 3.85) 0.45 (0.09, 2.03) 0.42 (0.11, 1.45) 0.36 (0.08, 1.52) 0.33 (0.07, 1.36) 0.59 (0.16, 1.89) 0.83 (0.28, 2.38)
Cis+Flu 1.54 (0.63, 4.03) 2.65 (0.62, 11.16) 2.61 (0.91, 7.46) 2.73 (1.07, 7.22) 1.31 (0.76, 2.26) 0.78 (0.22, 2.77) 2.66 (0.84, 8.77) Cis+Flu 0.38 (0.11, 1.24) 0.34 (0.07, 1.83) 1.83 (0.42, 7.83) 1.41 (0.28, 8.31) 0.95 (0.24, 3.65) 2.30 (0.72, 7.41) 1.18 (0.36, 3.93) 1.11 (0.51, 2.43) 0.96 (0.33, 2.58) 0.86 (0.29, 2.49) 1.57 (0.77, 2.83) 2.21 (1.40, 3.53)
Cis+Ifo 4.08 (1.35, 13.49) 7.12 (1.17, 42.43) 6.91 (1.55, 31.52) 7.30 (1.74, 30.66) 3.47 (1.13, 11.09) 2.06 (0.41, 10.46) 7.10 (1.48, 35.27) 2.65 (0.81, 9.06) Cis+Ifo 0.90 (0.30, 2.89) 4.87 (0.78, 30.22) 3.71 (0.92, 18.13) 2.51 (0.46, 13.93) 6.09 (1.28, 29.86) 3.15 (0.62, 15.87) 2.96 (0.81, 11.07) 2.53 (0.57, 10.86) 2.29 (0.51, 10.21) 4.14 (1.12, 14.63) 5.86 (1.90, 19.01)
Cis+Ifo+Pac 4.53 (0.92, 22.95) 7.72 (0.93, 64.19) 7.58 (1.15, 48.69) 8.00 (1.27, 47.80) 3.81 (0.76, 18.89) 2.28 (0.31, 16.11) 7.78 (1.09, 54.27) 2.92 (0.55, 14.99) 1.11 (0.35, 3.31) Cis+Ifo+Pac 5.36 (0.61, 44.30) 4.10 (0.69, 27.85) 2.75 (0.35, 20.72) 6.67 (0.94, 47.95) 3.43 (0.48, 25.04) 3.25 (0.58, 18.35) 2.79 (0.43, 16.82) 2.52 (0.39, 16.28) 4.61 (0.79, 23.56) 6.47 (1.28, 31.85)
Cis+Methotrexate 0.85 (0.17, 4.28) 1.45 (0.21, 10.09) 1.42 (0.27, 7.68) 1.49 (0.30, 7.58) 0.72 (0.17, 3.11) 0.43 (0.07, 2.67) 1.46 (0.26, 8.52) 0.55 (0.13, 2.36) 0.21 (0.03, 1.28) 0.19 (0.02, 1.63) Cis+Methotrexate 0.78 (0.10, 6.92) 0.51 (0.08, 3.57) 1.26 (0.22, 7.11) 0.65 (0.11, 3.91) 0.61 (0.13, 2.83) 0.52 (0.09, 2.79) 0.47 (0.09, 2.50) 0.86 (0.19, 3.69) 1.21 (0.31, 4.82)
Cis+Mitolactol 1.09 (0.19, 5.90) 1.90 (0.20, 15.11) 1.85 (0.26, 11.69) 1.97 (0.28, 11.13) 0.93 (0.17, 4.32) 0.55 (0.07, 3.78) 1.89 (0.25, 12.86) 0.71 (0.12, 3.55) 0.27 (0.06, 1.09) 0.24 (0.04, 1.46) 1.29 (0.14, 10.22) Cis+Mitolactol 0.67 (0.08, 4.90) 1.64 (0.21, 10.64) 0.84 (0.10, 5.77) 0.79 (0.12, 4.18) 0.68 (0.09, 4.06) 0.62 (0.08, 3.85) 1.11 (0.17, 5.60) 1.58 (0.27, 7.52)
Cis+Topotecan 1.63 (0.35, 7.93) 2.79 (0.41, 19.03) 2.74 (0.54, 14.35) 2.90 (0.59, 14.27) 1.37 (0.39, 4.81) 0.82 (0.15, 4.47) 2.80 (0.52, 15.94) 1.05 (0.27, 4.13) 0.40 (0.07, 2.18) 0.36 (0.05, 2.88) 1.94 (0.28, 12.66) 1.50 (0.20, 12.39) Cis+Topotecan 2.41 (0.43, 13.44) 1.25 (0.22, 6.98) 1.18 (0.28, 4.94) 1.01 (0.20, 4.66) 0.90 (0.18, 4.57) 1.65 (0.39, 6.37) 2.33 (0.61, 8.94)
Cis+Vcr 0.67 (0.18, 2.70) 1.16 (0.20, 6.39) 1.12 (0.27, 4.91) 1.19 (0.31, 4.66) 0.57 (0.18, 1.82) 0.34 (0.07, 1.75) 1.15 (0.26, 5.20) 0.43 (0.13, 1.39) 0.16 (0.03, 0.78) 0.15 (0.02, 1.06) 0.79 (0.14, 4.46) 0.61 (0.09, 4.77) 0.41 (0.07, 2.32) Cis+Vcr 0.52 (0.11, 2.40) 0.49 (0.14, 1.68) 0.42 (0.09, 1.74) 0.38 (0.09, 1.62) 0.68 (0.19, 2.18) 0.96 (0.33, 2.83)
Epi 1.30 (0.34, 5.48) 2.25 (0.38, 13.27) 2.19 (0.50, 9.60) 2.30 (0.59, 9.59) 1.10 (0.33, 3.66) 0.66 (0.12, 3.45) 2.24 (0.49, 10.59) 0.85 (0.25, 2.78) 0.32 (0.06, 1.60) 0.29 (0.04, 2.07) 1.54 (0.26, 9.12) 1.19 (0.17, 9.58) 0.80 (0.14, 4.63) 1.93 (0.42, 9.12) Epi 0.94 (0.26, 3.39) 0.81 (0.18, 3.45) 0.72 (0.16, 3.21) 1.32 (0.36, 4.47) 1.87 (0.62, 5.71)
Flu 1.37 (0.50, 4.04) 2.38 (0.52, 11.00) 2.34 (0.73, 7.50) 2.46 (0.85, 7.23) 1.17 (0.59, 2.38) 0.69 (0.18, 2.71) 2.38 (0.69, 8.71) 0.90 (0.41, 1.96) 0.34 (0.09, 1.24) 0.31 (0.05, 1.73) 1.64 (0.35, 7.77) 1.26 (0.24, 8.06) 0.85 (0.20, 3.58) 2.06 (0.59, 7.20) 1.06 (0.30, 3.92) Flu 0.86 (0.26, 2.69) 0.77 (0.29, 2.11) 1.41 (0.56, 3.16) 1.98 (1.03, 3.91)
Cis+Flu+Hyd 1.61 (0.47, 6.28) 2.79 (0.53, 15.34) 2.72 (0.69, 11.11) 2.85 (0.79, 11.08) 1.36 (0.54, 3.74) 0.81 (0.19, 3.82) 2.79 (0.66, 12.37) 1.04 (0.39, 3.05) 0.39 (0.09, 1.76) 0.36 (0.06, 2.34) 1.91 (0.36, 10.73) 1.47 (0.25, 10.55) 0.99 (0.21, 5.00) 2.39 (0.57, 10.76) 1.24 (0.29, 5.68) 1.16 (0.37, 3.81) Cis+Flu+Hyd 0.90 (0.24, 3.75) 1.64 (0.61, 4.13) 2.30 (0.88, 6.50)
Flu+MitoC 1.78 (0.52, 6.68) 3.07 (0.57, 16.69) 3.02 (0.78, 11.79) 3.18 (0.90, 11.66) 1.51 (0.53, 4.27) 0.90 (0.19, 4.32) 3.06 (0.74, 13.35) 1.16 (0.40, 3.43) 0.44 (0.10, 1.95) 0.40 (0.06, 2.58) 2.11 (0.40, 11.57) 1.62 (0.26, 11.85) 1.11 (0.22, 5.51) 2.66 (0.62, 11.38) 1.38 (0.31, 6.10) 1.29 (0.47, 3.44) 1.11 (0.27, 4.24) Flu+MitoC 1.82 (0.56, 5.36) 2.56 (0.95, 6.80)
Hyd 0.98 (0.37, 3.02) 1.69 (0.40, 7.94) 1.67 (0.56, 5.31) 1.75 (0.66, 5.30) 0.83 (0.46, 1.70) 0.50 (0.14, 2.00) 1.69 (0.53, 6.32) 0.64 (0.35, 1.29) 0.24 (0.07, 0.89) 0.22 (0.04, 1.27) 1.16 (0.27, 5.40) 0.90 (0.18, 5.81) 0.61 (0.16, 2.58) 1.46 (0.46, 5.29) 0.76 (0.22, 2.80) 0.71 (0.32, 1.79) 0.61 (0.24, 1.63) 0.55 (0.19, 1.79) Hyd 1.41 (0.81, 2.73)
Placebo 0.70 (0.31, 1.64) 1.19 (0.30, 4.73) 1.18 (0.46, 3.05) 1.24 (0.54, 2.85) 0.59 (0.37, 0.94) 0.35 (0.10, 1.23) 1.20 (0.42, 3.60) 0.45 (0.28, 0.71) 0.17 (0.05, 0.53) 0.15 (0.03, 0.78) 0.83 (0.21, 3.27) 0.63 (0.13, 3.66) 0.43 (0.11, 1.64) 1.04 (0.35, 3.03) 0.54 (0.18, 1.61) 0.51 (0.26, 0.97) 0.43 (0.15, 1.13) 0.39 (0.15, 1.05) 0.71 (0.37, 1.24) Placebo